PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
08-Oct-2025 North America Cheese Analogue Market Analysis Report 2025-2032: Vegan and Flexitarian Demand, Precision Fermentation and Foodservice Adoption Drive Growth - ResearchAndMarkets.com Businesswire
08-Oct-2025 Glaukos to Release Third Quarter 2025 Financial Results after Market Close on October 29 Businesswire
08-Oct-2025 Mikael Dolsten, M.D., Ph.D., Joins TRIO Pharmaceuticals as Chairman Businesswire
08-Oct-2025 VectorBuilder Redefines Plasmid Standards with miniVec Businesswire
08-Oct-2025 Peek Healthcare Technologies, Inc. ('Peek') Launches Direct-to-Employer and Direct-to-Patient Pricing for IMULDOSA(R) (ustekinumab-srlf) (Stelara(R) Biosimilar) ACCESS Newswire
08-Oct-2025 Mobility: The New Measure of Aging ACCESS Newswire
08-Oct-2025 Xenco Medical is Named the Medical Device/Diagnostics Company of the Year at the Prestigious 2025 Trailblazer Awards in New York City Businesswire
08-Oct-2025 Dr. Jennifer Robinson Calls for Greater Access to Mental Health Care ACCESS Newswire
08-Oct-2025 Belhaven Biopharma Initiates a Pivotal Biocomparability Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Nasdepi(R) vs. Epinephrine Intramuscular Injections ACCESS Newswire
08-Oct-2025 Duly Health and Care Physicians Now Offering Access to Galleri(R) Multi-Cancer Early Detection Test ACCESS Newswire
08-Oct-2025 FairJourney Biologics Appoints Dr. Werner Lanthaler as Chief Executive Officer Businesswire
08-Oct-2025 Clustermarket Rebrands to Calira and Secures Industry Veteran to Capitalise on Demand for Optimised R&D Lab Operations Businesswire
08-Oct-2025 AlphaMedixTM (212Pb-DOTAMTATE) achieved all primary efficacy endpoints in phase 2 study, demonstrating clinically meaningful benefits in patients with gastroenteropancreatic neuroendocrine tumors AlphaMedixTM (212Pb-DOTAMTATE)
08-Oct-2025 AlphaMedixTM (212Pb-DOTAMTATE) achieved all primary efficacy endpoints in phase 2 study, demonstrating clinically meaningful benefits in patients with gastroenteropancreatic neuroendocrine tumors AlphaMedixTM (
08-Oct-2025 Portzamparc – BNP Paribas Group Initiates Coverage of ONWARD Medical with a Buy Rating and Target Price of EUR 10.20 Portzamparc
08-Oct-2025 Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds Microbot Medical
08-Oct-2025 Medical Care Technologies (OTC PINK:MDCE) Initiates Preparatory Phase for Self-Conducted Research Studies on AI Mental Health and Preventive Biometrics Modules ACCESS Newswire
08-Oct-2025 Aptevo Presenting Scientific and Clinical Updates at SITC and ASH, also Participating in Leading Financial and Industry Conferences in the Fourth Quarter ACCESS Newswire
08-Oct-2025 Macomics Announces Neurodegeneration and Neuroinflammation Applications of ENIGMAC Drug Discovery Platform Macomics
08-Oct-2025 Rezolut Launches SubtleHD: More Comfortable MRI Scans, Sharper Results ACCESS Newswire